Baxter Announces US Approval and Launch of Ready-to-Use Cardiovascular Medicine Norepinephrine in Premix Formulation

By
Justin.choi
-
0
31
Baxter International, Inc. announced the US FDA approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection.
[Baxter International Inc.]

Sorry, but the selected Zotpress account can't be found.

Press Release